RETROSPECTIVE STUDY OF A SURGICAL PROTOCOL, COMPLICATIONS AND SURVIVAL OF DENTAL IMPLANTS PLACED IN PATIENTS WITH VON WILLEBRAND DISEASE
Main Article Content
Abstract
Von Willebrand's disease, described by Erik von Willebrand, is the most frequent hemorrhagic disorder. Its main symptom is mucosal bleeding. Willebrand's disease occurs due to a qualitative or quantitative defect of the von Willebrand factor molecule and follows an autosomal inheritance pattern. For dental implant placement, the treatment of hemorrhage caused by this disease requires close collaboration between hematologists and oral surgeons.
The aim of this study was to evaluate the clinical success rate of dental implants and the incidence of bleeding in patients with von Willebrand's disease when a local surgical protocol was applied, supported by systemic and local hemostatic measures. A retrospective study was performed between January 2018 and December 2023 on patients over 18 years old diagnosed with von Willebrand's disease. All patients had an interview with their hematologist to determine whether they needed a single preoperative dose of Desmopressin acetate. A surgical implant protocol was implemented, supported by systemic and local hemostatic measures. Data on age, sex, type of von Willebrand's disease, Desmopressin acetate administration, and whether implants were immediate or deferred, flapless or minimally invasive were collected from the medical records. The success rate was evaluated considering absence of pain, mobility and suppuration. Implant stability was measured using a resonance frequency analyzer (Osstell). Data were described by frequencies and percentages with 95% confidence intervals or summary measures, as appropriate. Twenty-eight surgeries were performed, placing 41 implants in 26 patients (23 females and 3 males), with a mean (range) age of 50.5 (23 to 72) years. Among the patients evaluated, 21 had type 1 von Willebrand's disease and one had type 2. No bleeding was recorded. Mean implant stability measured with the Osstell frequency analyzer was 71.
Implant stability and success rate in patients with Willebrand's disease was similar to that reported in other studies on patients without systemic disorders. Systemic and local protocols are essential to avoid complications and ensure successful treatment.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Berntorp E, Peake I, Budde U, Laffan M, Montgomery R, Windyga J, et al. Willebrand’s disease: a report from a meeting in the Åland islands. Haemophilia 2012 Sep;18 Suppl 6: 1-13.
3. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, et al. Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006 Oct; 4 (10): 2103-14.
4. Nichols WL , Hultin MB , James AH , et al. Von Willebrand disease (VWD): Evidence - based diagnosis and management guidelines, the national heart, lung, and blood institute (NHLBI) expert panel report (USA) . Haemophilia 2008 ; 14 : 171 – 232 .
5. Aparna M. A medical elaboration on von Willebrand disease with its dental management. J Oral Maxillofac Surg Med Pathol 2016; 28: 442-5. [http://dx.doi.org/10.1016/j.ajoms.2016.06.005]
6. Williams M, Patel J. Von Willebrand disease: Diagnosis and management. Paediatr Child Health 2015; 25: 354-9. [http://dx.doi.org/10.1016/j.paed.2015.05.005]
7. Connell NT, Flood VH, Brignardello-Petersen R, Abdul-Kadir R, Arapshian A, Couper S, Grow JM, Kouides P, Laffan M, Lavin M, Leebeek FWG, O'Brien SH, Ozelo MC, Tosetto A, Weyand AC, James PD, Kalot MA, Husainat N, Mustafa RA. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/blood advances.2020003264. PMID: 33570647; PMCID: PMC7805326.
8. Davis A, Walsh M, McCarthy P, Brown G, Roberts S, Tran H, Street A, Fong CY, Kemp W. Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study. Haemophilia. 2013 Jul;19(4):583-9. doi: 10.1111/hae.12146. Epub 2013 Apr 8. PMID: 23560720.
9. Mazzeffi MA, Stone ME. Perioperative management of von Willebrand disease: A review for the anesthesiologist. J Clin Anesth 2011; 23(5): 418-26. [http://dx.doi.org/10.1016/j.jclinane.2011.02.003] [PMID: 21741810]
10. Diz P, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent 2013; 41(3): 195-206. [http://dx.doi.org/10.1016/j.jdent.2012.12.008] [PMID: 23313715]
11. Pérez-Fierro M, Castellanos-Cosano L, Hueto-Madrid JA, López-Jiménez J, Núñez-Vázquez RJ, Machuca-Portillo G. 2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies. Med Oral Patol Oral Cir Bucal. 2023 Nov 1;28(6):e572-e580. doi: 10.4317/ medor al.25997. PMID: 37099709; PMCID: PMC10635626.
12. Kang M, Kang P. Dental Implant Therapy on a Patient With von Willebrand Disease: A Case Study. Implant Dent. 2018 Oct;27(5):599-601. doi: 10.1097/ID.0000000000000821. PMID: 30211710.
13. Fénelon M, Castet S, Fricain JC, Catros S. Guided Implant Surgery to Reduce Morbidity in Von Willebrand Disease Patients: A Case Report. Open Dent J. 2018 Jan 31;12:80-86. doi: 10.2174 /1874210601812010080. PMID: 29492173; PMCID : PMC5815035.
14. Gatti PC, Parreira M, Gutierrez Fillol A, Gualtieri A, Puia SA. Prospective observational study on the clinical behaviour of dental implants in patients with haemophilia. Preliminary results. Br J Oral Maxillofac Surg. 2022 Feb;60(2):157-161. doi: 10.1016/j.bjoms.2021.03.014. Epub 2021 Mar 31. PMID: 34916098.
15. Sharaf B,Jandali-Rifai M, Susarla SM, et al. Do perioperative antibiotics decrease implant failure? J Oral Maxillofac Surg 2011;69:2345–50.
16. Ostman PO, Hellman M, Wendelhag I, Sennerby L. Resonance frequency analysis measurements of implants at placement surgery. Int J Prosthodont. 2006;19:77–83. [PubMed] [Google Scholar]
17. R Core Team (2023). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/ .
18. Signorell A (2023). DescTools: Tools for Descriptive Statistics_. R package version 0.99.49, https://CRAN.R-project.org/package=DescTools
19. Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag.
20. Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lorenz C. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia. 2005;11:504–9.
21. Hewson ID, Daly J, Hallett KB, Liberali SA, Scott CL, Spaile G, Widmer R, Winters J. Consensus statement by hospital based dentists providing dental treatment for patients with inherited bleeding disorders. Aust Dent J. 2011 Jun;56(2):22 1-6. doi: 10.1111/j.1834-7819.2011.01328.x. PMID: 21623817.
22. Lewandowski B, Wojnar J, Brodowski R, Mucha M, Czenczek-Lewandowska E, Brzęcka D. Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation. Pol Arch Intern Med. 2018 Aug 31;128(7-8):488-490. doi: 10.2045 2/pamw.4298. Epub 2018 Jul 11. PMID: 30057379.
23. Anderson JA, Brewer A, Creagh D, et al. Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J. 2013; 215: 497-504.
24. Bajkin BV, Rajic NV, Vujkov SB. Dental extraction in a hemophilia patient without factor replacement therapy: a case report. J Oral Maxillofac Surg. 2012; 70: 2276-2277.
25. Bacci C, Berengo M, Favero L, et al. Safety of dental implant surgery in patients undergoing anticoagulation therapy: a prospective case–control study. Clin Oral Impl Res 2011;22:151–6.
26. Clemm R, Neukam FW, Rusche B, et al. Management of anticoagulated patients in implant therapy: a clinical comparative study. Clin Oral Impl\ Res 2016;27:1274–82.
27. van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev. 2015 Dec 24;(12):CD011385. doi: 10.1002/14651858. CD011385.pub2. Update in: Cochrane Database Syst Rev. 2019 Apr 19;4:CD011385. PMID: 26704192.
28. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999 Jun;57(6):1005-32. doi: 10.2165/00003495- 199957060-00017. PMID: 10400410.
29. Gornitsky M, Hammouda W, Rosen H. Rehabilitation of a hemophiliac with implants: a medical perspective and case report. J Oral Maxillofac Surg. 2005 May;63(5):592-7. doi: 10.1016/j.joms.2005.01.009. PMID: 15883931.
30. Castellanos-Cosano L, N..ez-V.zquez RJ, Segura-Egea JJ, Torres- Lagares D, Corcuera-Flores JR, Machuca-Portillo G. Protocol for oral implant rehabilitation in a hemophilic HIV-positive patient with type C hepatitis. Implant Dent. 2014 Oct;23(5):622-5. doi: 10.1097/ID.00000000000001 45. PMID:25238270.
31. Vassallo M, Zamberlin J, Roig MD, Macchi R, Aguilar JE. Efficacy of Local Hemostatic Management in Implant Surgery in Anticoagulated Patients on Warfarin: A Randomized Clinical Study. Int J Oral Maxillofac Implants. 2023 May, Jun;38(3): 545-552. doi: 10.11607/jomi.9846. PMID: 37279226.
32. Gandhi Y, Bhatavdekar N. MIDAS (Minimally Invasive Drilling And Styptic) protocol - A modified approach to treating patients under therapeutic anticoagulants. J Oral Biol Craniofac Res. 2019 Jul-Sep;9(3):208-211. doi: 10.1016/j.jobcr.2019.04.00 6. Epub 2019 Apr 30. PMID: 31193025; PMCID: PMC6514263.
33. Arisan V, Karabuda CZ, Ozdemir T. Implant surgery using bone- and mucosa-supported stereolithographic guides in totally edentulous jaws: Surgical and post-operative outcomes of computer-aided vs. standard techniques. Clin Oral Implants Res 2010; 21(9): 980-8. [PMID: 20497439]
34. Goldmann G, Berens C, Marquardt N, Reich R, Oldenburg J, Wenghoefer M. No increased bleeding risk for oral surgery in patients with severe congenital bleeding disorders due to intense perioperative management. Oral Maxillofac Surg. 2015 Jun;19(2):195-200. doi: 10.1007/s10006-014-0476-z. Epub 2014 Dec 10. PMID: 25488716.
35. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci. 1998 Feb;106(1): 527-51. doi: 10.1046/j.0909- 8836..t01-2-.x. PMID: 9527353.
36. Gasthi A, Rao UM, Alharethi N, Awinashe V, Sayed AJ, Parihar AS, Manas A. Comparative Evaluation of Two Implant Designs Based on Bone Loss and Stability with Early Loading Method. J Pharm Bioallied Sci. 2023 Jul;15(Suppl 2):S885-S887. doi: 10.4103/jpbs.jpbs_84_23. Epub 2023 Apr 28. PMID: 37694065; PMCID: PMC10485410.
37. Cochran DL, Jackson JM, Jones AA, Jones JD, Kaiser DA, Taylor TD, Weber HP, Higginbottom FL, Richardson JR, Oates T. A 5-year prospective multicenter clinical trial of non-submerged dental implants with a titanium plasma-sprayed surface in 200 patients. J Periodontol. 2011 Jul;82(7):990-9. doi: 10.1902/jop.2011.100464. Epub 2011 Jan 14. PMID: 21235337.